Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions-Reference-Cited by-同舟云学术

Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions

Published:2016-11-29 Issue: Volume:7 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Yizengaw Endalew,Getahun Mulusew,Tajebe Fitsumbrhan,Cruz Cervera Edward,Adem Emebet,Mesfin Getnet,Hailu Asrat,Van der Auwera Gert,Yardley Vanessa,Lemma Mulualem,Skhedy Ziv,Diro Ermias,Yeshanew Arega,Melkamu Roma,Mengesha Bewketu,Modolell Manuel,Munder Markus,Müller Ingrid,Takele Yegnasew,Kropf Pascale

Funder

Wellcome Trust

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference68 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS One,2012

2. Complexities of assessing the disease burden attributable to leishmaniasis;Bern;PLoS Negl Trop Dis,2008

3. Interleukin-10 and the pathogenesis of human visceral leishmaniasis;Nylen;Trends Immunol,2007

4. Immunoactivation and immunopathogeny during active visceral leishmaniasis;Goto;Rev Inst Med Trop Sao Paulo,2009

5. Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study;Gidwani;PLoS Negl Trop Dis,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasis;Frontiers in Immunology;2024-08-13

2. Distinct neutrophil effector functions in response to different isolates ofLeishmania aethiopica;2024-07-01

3. Serological characteristics and clinical implications of IgG subclasses in visceral leishmaniasis;Tropical Medicine & International Health;2023-12-30

4. Elucidating the role played by bone marrow in visceral leishmaniasis;Frontiers in Cellular and Infection Microbiology;2023-10-04

5. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach;Journal of Molecular Modeling;2023-03-16